These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15810179)

  • 41. University later admits that regulations were not followed.
    Maloney DM
    Hum Res Rep; 2002 Feb; 17(2):6-7. PubMed ID: 12374176
    [No Abstract]   [Full Text] [Related]  

  • 42. University failed to have adequate IRB policies and procedures in place.
    Maloney DM
    Hum Res Rep; 2002 Mar; 17(3):6-7. PubMed ID: 12408153
    [No Abstract]   [Full Text] [Related]  

  • 43. Lawsuits target medical research.
    Dembner A
    IRB; 2002; 24(4):14-5. PubMed ID: 13678031
    [No Abstract]   [Full Text] [Related]  

  • 44. The basics of human subjects protection.
    Yoder LH
    Medsurg Nurs; 2006 Apr; 15(2):95-8; quiz 99. PubMed ID: 16700248
    [No Abstract]   [Full Text] [Related]  

  • 45. The right of subjects to see the protocol.
    Veatch RM
    IRB; 2002; 24(5):6-8. PubMed ID: 12737168
    [No Abstract]   [Full Text] [Related]  

  • 46. Why wasn't an investigational new drug (IND) application required before appropriate study?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):6-7. PubMed ID: 15139342
    [No Abstract]   [Full Text] [Related]  

  • 47. Fatal drug trial raises questions about 'informed consent'.
    Altman LK
    N Y Times Web; 1993 Oct; ():C3. PubMed ID: 11647940
    [No Abstract]   [Full Text] [Related]  

  • 48. Privacy and studying services for rape victims.
    Shannon TA
    IRB; 1980; 2(6):8-9. PubMed ID: 11661805
    [No Abstract]   [Full Text] [Related]  

  • 49. Veterans affairs still has human research problems.
    Maloney DM
    Hum Res Rep; 2000 Dec; 15(12):3. PubMed ID: 11789517
    [No Abstract]   [Full Text] [Related]  

  • 50. OHRP action shuts down quality improvement research in Michigan.
    Healthcare Benchmarks Qual Improv; 2008 Mar; 15(3):25-8. PubMed ID: 18447247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New human subject protection regulations are being delayed.
    Maloney DM
    Hum Res Rep; 2005 Jan; 20(1):1-2. PubMed ID: 15810181
    [No Abstract]   [Full Text] [Related]  

  • 52. Beyond compliance...is it too much to ask?
    Koski G
    IRB; 2003; 25(5):5-6. PubMed ID: 14870726
    [No Abstract]   [Full Text] [Related]  

  • 53. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 54. Harming through protection?
    Baily MA
    N Engl J Med; 2008 Feb; 358(8):768-9. PubMed ID: 18287599
    [No Abstract]   [Full Text] [Related]  

  • 55. Institutional review boards as an instrument of assessment: research involving human subjects in the U.S.
    Gray BH
    Sci Technol Human Values; 1978; (25):. PubMed ID: 11663042
    [No Abstract]   [Full Text] [Related]  

  • 56. Court refuses to interfere with institutional review board (IRB).
    Maloney DM
    Hum Res Rep; 2003 Apr; 18(4):8. PubMed ID: 14603945
    [No Abstract]   [Full Text] [Related]  

  • 57. University says research subjects' family members are not research subjects too.
    Maloney DM
    Hum Res Rep; 2005 Feb; 20(2):6-7. PubMed ID: 15839006
    [No Abstract]   [Full Text] [Related]  

  • 58. Protecting vulnerable research subjects: practical realities of institutional review board review and approval.
    Wichman A
    J Health Care Law Policy; 1998; 1(1):88-104. PubMed ID: 15573431
    [No Abstract]   [Full Text] [Related]  

  • 59. Spate of suspensions of academic research spurs questions about federal strategy: a U.S. agency, its own future uncertain, unsettles college officials with its crackdown.
    Brainard J
    Chron High Educ; 2000 Feb; 96(22):A29-30, A32. PubMed ID: 15744907
    [No Abstract]   [Full Text] [Related]  

  • 60. Regulating human gene therapy: legislative overreaction to human subject protection failures.
    Leavitt WJ
    Adm Law Rev; 2001; 53(1):315-41. PubMed ID: 16189905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.